Anastasios G. Konidaris
Executive VP & CFOMr. Anastasios G. Konidaris, also known as Tasos, is Executive Vice President & Chief Financial Officer of Amneal Pharmaceuticals LLC. Mr. Konidaris has been an Executive Vice President at Amneal Pharmaceuticals, Inc. since August 2020 and serves as its Chief Financial Officer since March 12, 2020. Mr. Konidaris served as Senior Vice President at Amneal Pharmaceuticals, Inc. since March 12, 2020 until 2020. He served as an Executive Vice President and Chief Financial Officer of Alcresta Therapeutics, Inc. since March 2016 until 2020. Mr. Konidaris served as Senior Advisor at Athyrium Capital Management LP. Mr. Konidaris served as the Head of Corporate Development and Executive Vice President at Ikaria, Inc., since October 2011 to 2015. He served as Chief Financial Officer and Senior Vice President at Ikaria, Inc. since October 2011 until May 2015. Mr. Konidaris served as the Chief Financial Officer and Senior Vice President of The Dun & Bradstreet Corporation from March 1, 2007 to May 2015. He served as a Leader of Finance Operations of The Dun & Bradstreet Corporation from March 2005 to February 2007 and Principal Accounting Officer from May 2005 to February 2007. He served with D&B and led the finance, accounting, risk management and investor relations functions and executed numerous capital market and M&A transactions. He has experience in general management and global finance operations, including a role as Group Vice President of a the Global Diversified Products Group Division at Schering-Plough from May 2004 to February 2005 and Group Vice President of Finance, Global Pharmaceutical Group from August 2003 to May 2004. He served as Vice President and Chief Financial Officer of North America and Global Business Management at Pharmacia Corporation since 2003, where he played a significant role in the integration of the global pharmaceutical groups of Pharmacia and Pfizer Inc. He served increasing responsibility positions at Rhone-Poulenc Rorer and Novartis Corporation. Mr. Konidaris served as Vice President of Finance at North America of Pharmacia Corporation from June 2000 to July 2003 and served senior leadership roles in finance, operations and marketing at Bristol-Myers Squibb and Sandoz Corporation. He has been Independent Chairman of the Board at Kadmon Holdings, Inc., since May 2019. He had been Interim Chairman at Kadmon Holdings, Inc., since January 04, 2019 until 2019. He has been a Director of Kadmon Holdings, Inc. since February 15, 2017. He has been a Director of Alcresta Therapeutics, Inc. since December 23, 2016. He served as a Non-Executive Independent Director of Pernix Therapeutics Holdings, Inc. since April 25, 2014 until November 15, 2017. He served as a Director of Delcath Systems, Inc. from July 5, 2012 to December 2014. Mr. Konidaris holds a Bachelor’s of Science degree (with honors) in Mathematics and finance from Gwynedd Mercy College in Gwynedd Valley, PA and an MBA from Drexel University.
Positions
- Company NameAmneal Pharmaceuticals, Inc.Stock CodeAMRXPositionExecutive VP & CFOColleagues
- CKChirag K. PatelCo-Founder, Co-CEO, President & Director
- PMPaul M. MeisterIndependent Chairman of the Board
- CPChintu PatelCo-Founder, Co-CEO & Director
- JBJason B. DalyExecutive VP, Chief Legal Officer & Corporate Secretary
- NSNikita ShahExecutive VP & Chief Human Resources Officer
- TCTed C. NarkIndependent Director
- JJJohn J. KielyIndependent Director
